A&E doctor Javid Abdelmoneim is on a mission to find out the truth about alcohol. In January, the government released its new alcohol guidelines. For men, the recommended weekly limit was cut by a third to 14 units per week, equivalent to about seven pints of beer, bringing it in line with the amount recommended for women. So what is behind the change? This is just one question of many that Javid aims to answer as he explores the science of drinking and the new evidence for the health risks of alcohol. Why do some people get drunk quicker than others? What is behind red wine's healthy reputation? Is a nightcap actually good for your sleep? Does lining your stomach work? And can alcohol actually make you eat more?
Angela Rippon investigates the disease that took her mother's life and is now starting to affect her friends. She undergoes a series of tests to discover if she has any early signs of the disease and makes the difficult decision about whether to take a genetic test that could predict her future risk. Along the way, Angela finds out some of the surprising ways people can help to protect themselves. She discovers why getting a good night's sleep could help prevent Alzheimer's and how learning a new language might be more effective than any current drug treatment. Angela also visits a number of people who are living with the disease, including Bob, the husband of one of her oldest friends. She meets families that carry a gene for early-onset Alzheimer's and discovers how they could be the best hope of finding a cure for this devastating disease.
2016 • Health
A treatment method that overturns a common sense of the medical community that "the brain cell does not regenerate" has been developed in Japan, and its practical application is imminent. The key to the treatment are "stem cells", which regenerate various body tissues on a daily basis. Japanese researchers have discovered that stem cells, which have been thought to be absent in adult brains, actually exist in small numbers. A therapy that stimulates brain stem cells in an innovative way and regenerates the brain is entering the final phase of a clinical trial.
We bring you a special episode, celebrating the award of this year's Nobel Prize in Physiology or Medicine to Tasuku Honjo, Distinguished Professor at Kyoto University. His basic research has led to the development and clinical applications of Opdivo, a groundbreaking new anti-cancer drug that works with immune cells. It has given hope to many cancer patients, and surprised clinical specialists. We'll explore what innovation Opdivo has brought to cancer treatment, and what challenges remain.